A. Brett
2004
Citations
0
Influential Citations
0
Citations
Quality indicators
Journal
NEJM Journal Watch
Abstract
Many patients with Parkinson disease develop dementia. In this industry-sponsored international randomized trial, researchers examined whether rivastigmine (Exelon) -- a cholinesterase inhibitor approved for use in Alzheimer disease -- is effective for Parkinson patients with mild-to-moderate dementia. A total of 541 patients received rivastigmine or placebo. At …